Partner Headlines - ILMN

  1. Small Caps Soar, Dow Off; Which Tech Stocks Beat Apple In Gains ...

    Investors Business Daily
  2. Nasdaq Chugs Higher; Apple Extends Gains On Product Buzz

    Investors Business Daily
  3. Illumina Jumps As Improved Sequencer Seen Sparking New Upgrade ...

    TalkMarkets
  4. Stock Futures Inch Up, Small Caps Quiet; Illumina, Bio-Rad, Qorvo ...

    Investors Business Daily
  5. Life Science Sector Review: Diagnostics and Tools Update

    TalkMarkets
  6. One Bright Idea

    TalkMarkets
  7. Week In Review: Suzhou's Innovent Biologics Announces Record ...

    TalkMarkets
  8. OraSure Stock Sets Up For Buy Point On Hep C Contract, Helix ...

    Investors Business Daily
  9. Market Reversal In Biotech But Healthcare Stocks Are Still Muddled ...

    TalkMarkets
  10. Biotech Bear Market Looking For Relief From Q3 Large Cap Growth

    TalkMarkets
  11. 5 Healthcare Stocks To Buy Despite A Clinton Victory

    TalkMarkets
  12. Biotechnology Bear Market: Trends To Watch For A 2016 Q4 Rally

    TalkMarkets
  13. Illumina Misses Revenue Forecast Causing Collateral Damage To ...

    TalkMarkets
  14. Illumina Plunges After Cutting Estimated Q3 Revenue View

    TalkMarkets
  15. Top Stock Stories At Midday: Oct. 11

    TalkMarkets
  16. 5 Large Caps For Momentum Investors - October 3, 2016

    TalkMarkets
  17. Rayno 2016 Life Science Portfolio Update

    TalkMarkets
  18. 5 Great Nasdaq 100 Stocks For Momentum Investors

    TalkMarkets
  19. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets
  20. Baron Funds Comments on Illumina Inc.

    GuruFocus
  21. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big ...

    IBD
  22. Stocks Open Down, Reverse Higher; Prestige, Nike, Fastenal Soar

    IBD
  23. Benzinga's Top Downgrades

    Benzinga
  24. Stock Indexes Trade Mixed, But Medicals Fall; Illumina Hits Low

    IBD
  25. Illumina Brings More Pain To Battered Biotech ETFs; Gold Hits ...

    IBD
  26. Illumina Names Dr. Frances Arnold to Board of Directors

    Benzinga
  27. Juno Buyout Puts Single-Cell Sequencing In Spotlight

    IBD
  28. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD
  29. Celgene, Vertex, Illumina Offer Mixed Outlooks

    IBD
  30. Illumina Forms GRAIL to Enable Early Cancer Detection via Blood-Based ...

    Benzinga
  31. Apple Supplier Avago A Top Pick; BlackBerry PT Hiked

    IBD
  32. Should You Wait to Bet on Agilent Technologies?

    GuruFocus
  33. Steve Mandel Acquires Stakes in Amazon.com and Constellation ...

    GuruFocus
  34. Desktop Genetics Receives Strategic Investment from Illumina

    Benzinga
  35. John Griffin Buys Autodesk, Apple, Sells AIG, Fitbit

    GuruFocus
  36. Julian Robertson Keeps Buying Citigroup, Netflix, Facebook

    GuruFocus
  37. Frank Sands Invests in Stake in Amazon.com

    GuruFocus
  38. Facebook, Apple, Gilead Honchos Lead Insider Deals

    IBD
  39. Benzinga's Volume Movers

    Benzinga
  40. Morning Market Gainers

    Benzinga
  41. Benzinga's Top #PreMarket Gainers

    Benzinga
  42. Don't Allow A Healthy Winner To Turn Into A Loser

    IBD
  43. Baron Funds Comments on Illumina Inc.

    GuruFocus
  44. Stocks Slip, Retake Slim Gains; Monster, Bank Of The Ozarks Rise

    IBD
  45. Benzinga's Top Downgrades

    Benzinga
  46. Nasdaq, S&P 500 End Win Streaks; Autobytel Gains

    IBD
  47. DuPont Cushions Dow; Chip Stocks, Biotechs Weigh On Nasdaq

    IBD
  48. Stocks Wrestle In Mixed Action; DuPont Surges, Illumina Dives

    IBD
  49. Morning Market Losers

    Benzinga
  50. Benzinga's Top Downgrades

    Benzinga
  51. Stock Futures Down, Off Lows On News From DuPont, Pepsi, Illumina

    IBD
  52. Illumina Downgraded; Apple Supplier Skyworks PT Cut

    IBD
  53. Benzinga's Top #PreMarket Losers

    Benzinga
  54. Illumina Plunges On Outlook

    IBD
  55. Stock Leadership Has Dumped Medical, Turned Diverse

    IBD
  56. Illumina Stock Dives On Latest Sales Warning

    IBD
  57. Genomics Out Of 'Caveman Era,' But Still A Ways To Go

    IBD
  58. Gilead, Valeant Downgraded; IBM, Dunkin' PTs Cut

    IBD
  59. Stocks End Narrowly Mixed Ahead Of Job Report

    IBD
  60. Illumina Tumbles On Downgrade, New Competition

    IBD
  61. Apple Supplier Skyworks Is A Buy; Celgene Upgraded

    IBD
  62. Stocks Move Lower; Slow Sales Take Bite Out Of Dunkin' Brands

    IBD
  63. Stocks Give Up Early Gains As Apple, Illumina, Sucampo Slide

    IBD
  64. Morning Market Losers

    Benzinga
  65. Benzinga's Top Downgrades

    Benzinga
  66. Apple Supplier Skyworks Is A Buy; Celgene Upgraded

    IBD
  67. Benzinga's Top #PreMarket Losers

    Benzinga
  68. Netflix, Google CEOs Top This Week's Insider Sales

    IBD
  69. BioMed Realty Trust REIT Looks For A Buyer

    IBD
  70. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
  71. Frank Sands Shows Bold Side in Second-Quarter Trades

    GuruFocus
  72. Perigon Wealth Management's Largest Buys in Second Quarter

    GuruFocus
  73. Benzinga's Top Initiations

    Benzinga
  74. Burning Rock, Illumina Announce Collaboration on Molecular Diagnostics ...

    Benzinga
  75. Baron Funds Comments on Illumina Inc.

    GuruFocus
  76. Baron Funds Comments on Illumina Inc.

    GuruFocus
  77. Illumina, Warburg Pincus, Sutter Hill Ventures Form Helix With ...

    Benzinga
  78. Good Stocks Differ, So Know What You're Looking At

    IBD
  79. Big Cap Leaders Sail Past Earnings Season

    IBD
  80. 4 IBD 50 Stocks Poised To Bounce Back With Market

    IBD
  81. Valeant, Starbucks Lead 5 IBD 50 Stocks Bucking Market

    IBD
  82. Bruised Apple Batters Stocks

    IBD
  83. Illumina Breaches Key Level On Q2 Sales Miss

    IBD
  84. Comeback Efforts Lose Steam; Lithia Revs Higher

    IBD
  85. Morning Market Losers

    Benzinga
  86. Stock Futures Down, Action Mixed; Apple, Vasco, Illumina Tumble

    IBD
  87. Benzinga's Top #PreMarket Losers

    Benzinga
  88. Illumina Disappoints On Sales

    IBD
  89. GoPro, Fitbit Surge As Indexes Dip; Apple Down Late

    IBD
  90. Illumina Stock Dives As Q2 Earnings Beat, Sales Miss

    IBD
  91. Stock Futures Mixed, IBM Weighs; Infosys, Tesla, Apple In Motion

    IBD
  92. Earnings Loom For Handful Of Top Big Cap 20 Stocks

    IBD
  93. Move Aside Apple: 8 IBD 50 Stocks With Earnings Due

    IBD
  94. Newfound Market Strength Could Benefit These IBD 50 Names

    IBD
  95. Google Rally Masks Weakness; Domino's Falls, SolarWinds Crushed

    IBD
  96. As Biotech Beats, 6 Top ETF Picks For Rest Of 2015

    IBD
  97. Big Cap 20: Biotech Red-Hot As Medicals Stay Dominant

    IBD
  98. Top Mutual Funds Add Abiomed, Tech Stocks And Monster

    IBD
  99. Big Cap 20: Does Edwards Lifesciences Have More Left?

    IBD
  100. 5 IBD 50 Stocks Hold Tight After Monday's Plunge

    IBD
Trading Center